Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.

Cuttica MJ, Langenickel T, Noguchi A, Machado RF, Gladwin MT, Boehm M.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):62-71. doi: 10.1165/rcmb.2009-0365OC. Epub 2010 Sep 2.

2.

Interleukin-6 overexpression induces pulmonary hypertension.

Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB.

Circ Res. 2009 Jan 30;104(2):236-44, 28p following 244. doi: 10.1161/CIRCRESAHA.108.182014. Epub 2008 Dec 12.

3.

Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Song Y, Coleman L, Shi J, Beppu H, Sato K, Walsh K, Loscalzo J, Zhang YY.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H677-90. doi: 10.1152/ajpheart.91519.2007. Epub 2008 Jun 13. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1544.

4.

Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.

Fu J, Chen YF, Zhao X, Creighton JR, Guo Y, Hage FG, Oparil S, Xing DD.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1539-47. doi: 10.1161/ATVBAHA.114.303821. Epub 2014 May 1.

5.

Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.

Shatat MA, Tian H, Zhang R, Tandon G, Hale A, Fritz JS, Zhou G, Martínez-González J, Rodríguez C, Champion HC, Jain MK, Hamik A.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):647-53. doi: 10.1165/rcmb.2013-0135OC.

6.

Pathology and pathobiology of pulmonary hypertension.

Guignabert C, Dorfmuller P.

Semin Respir Crit Care Med. 2013 Oct;34(5):551-9. doi: 10.1055/s-0033-1356496. Epub 2013 Sep 13. Review.

PMID:
24037624
7.

[The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].

Kayikçioğlu M.

Anadolu Kardiyol Derg. 2010 Aug;10 Suppl 1:5-8. doi: 10.5152/akd.2010.113. Review. Turkish.

8.

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L583-90. Epub 2007 Jun 22.

9.

Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.

Nave AH, Mižíková I, Niess G, Steenbock H, Reichenberger F, Talavera ML, Veit F, Herold S, Mayer K, Vadász I, Weissmann N, Seeger W, Brinckmann J, Morty RE.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1446-58. doi: 10.1161/ATVBAHA.114.303534. Epub 2014 May 15.

10.

Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.

Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.

Respir Res. 2014 Nov 25;15:148. doi: 10.1186/s12931-014-0148-4. Erratum in: Respir Res. 2016 Nov 4;17 (1):142.

11.

Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.

Van Hung T, Emoto N, Vignon-Zellweger N, Nakayama K, Yagi K, Suzuki Y, Hirata K.

Life Sci. 2014 Nov 24;118(2):313-28. doi: 10.1016/j.lfs.2013.12.215. Epub 2014 Jan 8.

12.

Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury.

Fee D, Crumbaugh A, Jacques T, Herdrich B, Sewell D, Auerbach D, Piaskowski S, Hart MN, Sandor M, Fabry Z.

J Neuroimmunol. 2003 Mar;136(1-2):54-66.

PMID:
12620643
13.

Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.

Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, Nagai R.

Circulation. 2007 Jan 30;115(4):509-17. Epub 2007 Jan 22.

14.

Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.

Sakao S, Tatsumi K, Voelkel NF.

Respir Res. 2009 Oct 13;10:95. doi: 10.1186/1465-9921-10-95. Review.

15.

Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation.

Larsen KO, Yndestad A, Sjaastad I, Løberg EM, Goverud IL, Halvorsen B, Jia J, Andreassen AK, Husberg C, Jonasson S, Lipp M, Christensen G, Aukrust P, Skjønsberg OH.

Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L50-9. doi: 10.1152/ajplung.00048.2010. Epub 2011 Apr 15.

16.

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.

Savale L, Tu L, Rideau D, Izziki M, Maitre B, Adnot S, Eddahibi S.

Respir Res. 2009 Jan 27;10:6. doi: 10.1186/1465-9921-10-6.

17.

Reversible or irreversible remodeling in pulmonary arterial hypertension.

Sakao S, Tatsumi K, Voelkel NF.

Am J Respir Cell Mol Biol. 2010 Dec;43(6):629-34. doi: 10.1165/rcmb.2009-0389TR. Epub 2009 Dec 11. Review.

18.

Endothelial fate mapping in mice with pulmonary hypertension.

Qiao L, Nishimura T, Shi L, Sessions D, Thrasher A, Trudell JR, Berry GJ, Pearl RG, Kao PN.

Circulation. 2014 Feb 11;129(6):692-703. doi: 10.1161/CIRCULATIONAHA.113.003734. Epub 2013 Nov 7.

19.

Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.

Hong KH, Lee YJ, Lee E, Park SO, Han C, Beppu H, Li E, Raizada MK, Bloch KD, Oh SP.

Circulation. 2008 Aug 12;118(7):722-30. doi: 10.1161/CIRCULATIONAHA.107.736801. Epub 2008 Jul 28.

20.

Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.

Kim FY, Barnes EA, Ying L, Chen C, Lee L, Alvira CM, Cornfield DN.

Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L368-77. doi: 10.1152/ajplung.00253.2014. Epub 2014 Nov 14.

Supplemental Content

Support Center